 |
Receptor Therapeutics Inc. has received seed financing from the GrowthWorks Canadian Fund Ltd. |
|
 |
OncoTek Drug Delivery Inc., a wholly owned subsidiary of Receptor Therapeutics Inc. is the recipient of an IP Development and Commercialization Investment from the Ontario Institute for Cancer Research. | |
 |
Receptor Therapeutics Inc. has received an Investment Accelerator Fund (IAF) investment from the Ontario Centres of Excellence. |
Receptor Therapeutics
